GlassScriptPhysician profile
Summer D Morgan
NPI 1770031593
$1,671.38
in general payments reported to CMS, 2019-2025
20 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $478 · 2022: $382 · 2023: $355 · 2024: $218 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $811.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $448.75 | 2021-2025 | |
| Organon LLC | $218.32 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $158.66 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $141.78 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $121.24 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $98.52 | 2021-2024 | |
| Myriad Women'S Health, INC. | $66.35 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $62.52 | 2022-2023 | Aptima, Thinprep 2000 Processor, Third Wave |
| Astellas Pharma US INC | $62.45 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $62.08 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $39.29 | 2022 | |
| Shield Therapeutics INC | $38.93 | 2024 | |
| Medtronic, INC. | $32.31 | 2021-2022 | |
| Pharmacyclics LLC, An Abbvie Company | $23.06 | 2021 | |
| Millicent US INC | $21.16 | 2025 | Intrarosa, Femlyv |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alydia Health | $17.84 | 2021 | |
| Organogenesis INC. | $17.83 | 2025 | Puraply Wound Matrix |
| Bayer Healthcare Pharmaceuticals INC. | $15.29 | 2025 | |
| Smith+Nephew, INC. | $13.02 | 2022 | |
| Becton, Dickinson and Company | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Summer Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.